Better Choice Co. 2023 annual meeting results: all four proposals approved by stockholders

SRx Health Solutions, Inc.

Elected directors: Lionel Conacher, Arlene Dickinson, Gil Fronzaglia, John Word III, Michael Young (each with >12.8M votes 'for').
Approved issuance of common stock upon exercise of Alphia Second Tranche Warrant (13.9M for, 0.8M against, 14k abstain).
Ratified BDO USA as independent auditor for FY 2023 (18.4M for, 120k against, 612k abstain).
Advisory vote approved named executive officer compensation (13.8M for, 903k against, 8.8k abstain).
Turnout: 19.1M shares (59.7% of outstanding) present or represented at the meeting.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

SRx Health Solutions, Inc. shareholders approved Reaffirmation of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-11-15 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-11-15

Exact text from the filing

The reaffirmation of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified, with votes as follows: FOR AGAINST ABSTAIN 18,417,460 119,791 611,901

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

SRx Health Solutions, Inc. shareholders approved Approval of issuance of common stock upon exercise of the Alphia Second Tranche Warrant at the 2023-11-15 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-11-15

Exact text from the filing

The vote to approve the issuance of common stock upon exercise of the Alphia Second Tranche Warrant, was as follows: FOR AGAINST ABSTAIN BROKER NON-VOTE 13,915,282 821,350 13,971 4,398,549

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

SRx Health Solutions, Inc. shareholders approved Advisory (non-binding) approval of compensation of named executive officers at the 2023-11-15 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-11-15

Exact text from the filing

The compensation of the Company’s named executive officers was approved, on an advisory (non-binding) basis, with votes as follows: FOR AGAINST ABSTAIN BROKER NON-VOTE 13,838,601 903,204 8,798 4,398,549

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

SRx Health Solutions, Inc. shareholders approved Election of directors at the 2023-11-15 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-11-15

Exact text from the filing

Each of the following persons was duly elected to serve as a director of the Company’s board of directors for a term expiring at the 2024 annual meeting of stockholders and until his or her successor shall have been elected and qualified or until earlier resignation, removal from office or death, with votes as follows:

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-041553

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.